Ultrasound-guided aspiration and ethanol sclerotherapy (EST) for treatment of cyst recurrence in patients after previous endometriosis surgery: analysis of influencing factors using a decision tree
Observational
OA: closed
CC0
⤵ 20 in-corpus citations
AI-generated summary
This study analyzes factors influencing ultrasound-guided aspiration and ethanol sclerotherapy success for recurrent endometriosis cysts after prior surgery, using a decision tree model.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
STUDY OBJECTIVE: To evaluate the efficiency of transvaginal aspiration accompanied by ethanol sclerotherapy for treating cyst recurrence in patients who have previously undergone surgery to treat endometriosis and to analyze various factors that influence success rates using a data mining system.
DESIGN: Retrospective cohort study (Canadian Task Force classification II-3).
SETTING: Teaching hospital affiliated with Chang Gung University, Taoyuan, Taiwan.
PATIENTS: One hundred ninety-six patients with endometrioma recurrence.
INTERVENTION: A total of 274 transvaginal aspirations followed by sclerotherapy with 95% ethanol. Treatment times varied from immediate removal (0-10 minutes) to in situ retention. Patients were followed up at 3, 6, and 12 months to detect complications, determine the size and persistence of cysts, obtain the pelvic pain score, and assess for pregnancy or the need for repeat surgical intervention. A decision tree was used to determine factors from the collected data that most influenced the success of treatment.
MEASUREMENTS AND MAIN RESULTS: Cyst size was consistently reduced until 6 months after ethanol sclerotherapy. The mean (SD) cyst reduction rate was 37.2% (42.2%), and the pain score reduction rate was 20.5% (71.5%). The antral follicle count was simultaneously increased by 36.4%. Sixty-three patients (23%) required repeated surgery during the observation period and were treated with either repeat aspiration (13.5%) or major laparoscopic or open laparotomic interventions (8.4%). Eighteen of 101 infertile patients (17.8%) achieved pregnancy. The total recovery rate (pregnancy or no persistence of symptoms or cyst) was significantly higher in patients in the groups that received longer treatment (7-10 minutes and retention) than in the groups with shorter treatment (0-6 minute) (47.0% vs 28.7%; p < .005). The highest recovery rate was observed in patients with longer treatment time, smaller cysts (≤5.05 cm), lower CA 125 level (≤62.03 IU/mL), and fewer cysts (≤3 cm) (35 of 49 [71.4%]). In patients with larger cysts and cysts with clear contents, better success can be achieved with longer treatment. The use of postoperative ovarian suppression, traditional Chinese medicine, or no therapy for 6 months before the study was not significant among groups.
CONCLUSION: Ultrasound-guided sclerotherapy with 95% ethanol retention is an effective alternative therapy for recurrent ovarian endometrioma, in particular in selected patient groups.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (31)
- CA 125 serum values in surgically treated endometriosis patients and its relationships with anatomic sites of endometriosis and pregnancy rate via openalex
- Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas via openalex
- Efficacy of ethanol sclerotherapy for ovarian endometriomas via openalex
- Laparoscopic findings after transvaginal ultrasound-guided aspiration of ovarian endometriomas via openalex
- Management of endometriomas in women requiring IVF: to touch or not to touch via openalex
- Management of ovarian endometriomas via openalex
- Minimally invasive gynecologic procedures via openalex
- Oxidative stress status in normal ovarian cortex surrounding ovarian endometriosis via openalex
- Pelvic abscess after ultrasound-guided aspiration of endometrioma: a case report via openalex
- Postoperative oral contraceptive exposure and risk of endometrioma recurrence via openalex
- Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis via openalex
- Recurrence of endometriomas after laparoscopic removal: sonographic and clinical follow-up and indication for second surgery via openalex
- Repeat transvaginal ultrasound-guided aspiration of ovarian endometrioma in infertile women with endometriosis via openalex
- Secondary infection of an endometrioma following fine-needle aspiration via openalex
- Sonographically guided therapeutic aspiration of benign-appearing ovarian cysts and endometriomas via openalex
- The effect of second-line surgery on reproductive performance of women with recurrent endometriosis: a systematic review via openalex
- The outcomes of repeat surgery for recurrent symptomatic endometriosis via openalex
- [Ultrasonically guided puncture of endometrial cysts--aspiration of contents and infusion of ethanol] via openalex
- W6605276091 via openalex
- W130409979 via openalex
- W1974626323 via openalex
- W1977520875 via openalex
- W1980447854 via openalex
- W2029026806 via openalex
- W2045264967 via openalex
- W2060595366 via openalex
- W2064755756 via openalex
- W2132577372 via openalex
- W2153952391 via openalex
- W2401134385 via openalex
- W6601375306 via openalex
Cited by (20)
- Risk Factors for Recurrence and Safety Outcomes After Ethanol Sclerotherapy for Ovarian Endometriomas 2026
- Treatment after endometrioma recurrence: a narrative review 2023
- How to Improve Non-Invasive Diagnosis of Endometriosis with Advanced Statistical Methods 2023
- Manejo conservador del endometrioma ovárico con escleroterapia usando etanol previo a fecundación in vitro 2023
- Ethanol Sclerotherapy versus Laparoscopic Surgery in Management of Ovarian Endometrioma; a Randomized Clinical Trial 2022
- Endométriose ovarienne 2022
- Contrast-enhanced ultrasound evaluation of a refractory ovarian endometrial cyst and ultrasound-guided aspiration sclerotherapy using urokinase and lauromacrogol 2021
- Aspiration versus retention ultrasound-guided ethanol sclerotherapy for treating endometrioma: A retrospective cross-sectional study 2020
- Ethanol Sclerotherapy versus Laparoscopic Surgery for Endometrioma Treatment: A Prospective, Multicenter, Cohort Pilot Study 2020
- Abdominal Wall Endometriosis: Purpose of a Case and Review of Literature 2020
- [Endometrioma and management by assisted reproductive technology: CNGOF-HAS Endometriosis Guidelines] 2018
- The effects of sclerotherapy with 5% trichloroacetic acid on the cyst diameter and ovarian tissue in the rat ovarian cyst model 2018
- Recovery Rate of Patients with Recurrent OvarianEndometriomas Using Sclerotherapywith 95% Ethanol 2018
- [Strategies and surgical management of endometriosis: CNGOF-HAS Endometriosis Guidelines] 2018
- Ovarian Endometrioma and Infertility 2017
- Pharmacologic treatment of the ovarian endometrioma 2016
- A systematic review of ultrasonography-guided transvaginal aspiration of recurrent ovarian endometrioma 2016
- A new approach to the management of ovarian endometrioma to prevent tissue damage and recurrence 2016
- Ethanol sclerotherapy of ovarian endometrioma: a safe and effective minimal invasive procedure. Preliminary results 2015
- Sclerotherapy with Ethanol: An Effective and Safe Alternative to Potentially Complex Surgical Treatment of Recurrent Ovarian Endometrioma 2015
Source provenance
- europepmc
- last seen: 2026-10-13T06:10:10.580696+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:12:41.142639+00:00
- unpaywall
- last seen: 2026-10-13T06:25:51.201866+00:00
License: CC0
· commercial use OK